PDL BioPharma, Inc. EBIT

EBIT of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT growth rates and interactive chart. Earnings before interest and taxes is an indicator of a company's profitability. One can calculate it as revenue minus all expenses, excluding tax and interest. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes. It is the amount of profit that a company earns before interest on debt and taxes are paid.


Highlights and Quick Summary

  • EBIT for the quarter ending June 29, 2020 was $-13.8 Million (a -56.82% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT decreased by -245.75%
  • Annual EBIT for 2019 was $-99.8 Million (a 97.28% increase from previous year)
  • Annual EBIT for 2018 was $-50.6 Million (a -126.11% decrease from previous year)
  • Annual EBIT for 2017 was $194 Million (a 49.75% increase from previous year)
  • Twelve month EBIT ending June 29, 2020 was $-128 Million (a 3.65% increase compared to previous quarter)
  • Twelve month trailing EBIT decreased by -602.54% year-over-year
Trailing EBIT for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-128 Million $-123 Million $-99.8 Million $25.5 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT of PDL BioPharma, Inc.

Most recent EBITof PDLI including historical data for past 10 years.

Interactive Chart of EBIT of PDL BioPharma, Inc.

PDL BioPharma, Inc. EBIT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-13.76 $-31.88
2019 $-91.78 $9.44 $-9.26 $-8.22 $-99.81
2018 $33.5 $36.74 $-125.13 $4.29 $-50.59
2017 $29.87 $32.62 $112.78 $18.51 $193.78
2016 $-7.67 $32.66 $11.14 $93.28 $129.4
2015 $161.53 $116.17 $130.64 $142.04 $550.38
2014 $99.35 $158.91 $155.83 $132.22 $546.31
2013 $107.85 $92.25 $141.74 $84.66 $426.51
2012 $84.67 $79.58 $120.76 $70.4 $355.41
2011 $67.99 $79.81 $118.35 $77.56 $343.7
2010 $-28.43 $75.33 $111.52 $211.08

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.